San Francisco, California, November 16, 2017: A fresh business and commerce study by TMR Research has projected the demand in the global coagulation analyzer market to expand at a double-digit CAGR during the forecast period of 2017 to 2025, primarily gaining traction from increasing prevalence of lifestyle associated diseases. The report, developed by a group of professional research analysts, aspires to serve as a decision-making tool for its targeted audiences such as coagulation analyzer and consumable manufacturers and suppliers, hospitals, clinical laboratories, pharmaceutical and biotechnology companies, and academic research institutes pertaining to coagulation testing market.
The report begins with an overview of the current scenario of the market for coagulation analyzer, provides in-depth analysis of market dynamics such as drivers, restraints, trends, and opportunities, segments the market into small aspects, gauges the potential of various important regions and countries, and profiles some of the key companies in order to represent the competitive landscape and how the recent strategies of these companies will affect their market dominance. The report has been developed with a goal to provide valuable product information and pertaining technologies.
As per the findings of the report, the demand in the global coagulation analyzer market will be driven by a number of factors such as increasing prevalence of cardiovascular diseases and blood disorders, rising percentage of geriatrics in global population, development of high-sensitivity POC coagulation testing, and increasing laboratory automation in order fetch desired result quickly and accurately. On the other hand, factors such as high cost of fully automated coagulation analyzer and slow adoption of advanced hemostasis instruments in various emerging economies is obstructing the market for coagulation analyzer to attain its true potential. Nevertheless, the vendors of this market are expected to focus on developed regions wherein healthcare infrastructure is improving and gain new revenue opportunities.
Product-wise, the global coagulation analyzer market can be segmented into systems that are automated, semi-automated, and manual, and consumables, which can be further sub-segmented into reagents, standards, controls, and calibrations. On the basis of test, the market for coagulation analyzer can be bifurcated into prothrombin time, activated clotting time, activated partial thromboplastin time, fibrinogen, D dimer, platelet function, herapin and protamine dose response test for ACT, anti-factor Xa, and other coagulation tests. Technology-wise, the market can be categorized into mechanical, electrochemical, optical, and other technologies, whereas the end users of this market can be clinical laboratories, POC, and other end users. Presently, the optical technology segment is gaining traction from its better flexibility and accuracy as well as ability to be applicable in coagulation analysis.
Geographically, the report takes stock of the potential of every important region, such as North America, Europe, Asia Pacific, and the Middle East and Africa. While North America currently serves the maximum demand, driven by the developed country of the U.S., which has robust healthcare infrastructure and a high percentage of geriatrics.
Some of the key companies operating in the global coagulation analyzer market are Roche Diagnostics, Alere Inc., Siemens AG, Sysmex Corporation, Thermo Fisher Scientific Inc., Nihon Kohden Corporation, Helena Laboratories, Diagnostica Stago, Instrumentation Laboratory, and International Technidyne Corporation. As far as the competitive landscape is concerned, the shares in this market distributed among a small chunk of players but not consolidated, per say. Most of the players are expanding their geographical presence in order to gain bigger share and improving their distribution network by making use of third party vendors.
Get Sample Copy of this Report